These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 12208796)

  • 21. Chlamydia pneumoniae infection in patients with acute coronary syndrome: a clinical and serological 1-year follow-up.
    Romano S; Fratini S; Di Pietro M; Schiavoni G; Nicoletti M; Chiarotti F; Del Piano M; Penco M; Sessa R
    Int J Immunopathol Pharmacol; 2004; 17(2):209-18. PubMed ID: 15171822
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Seroprevalence of IgG antibodies to Chlamydia pneumoniae and Helicobacter pylori among coronary heart disease patients and normal individuals in South Indian population.
    Chaudhury A; Rajasekhar D; Latheef SA; Subramanyam G
    Indian J Pathol Microbiol; 2004 Jul; 47(3):433-4. PubMed ID: 16295450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chlamydia pneumoniae immunoreactivity in coronary artery plaques of patients with acute coronary syndromes and its relation with serology.
    Liu R; Yamamoto M; Moroi M; Kubota T; Ono T; Funatsu A; Komatsu H; Tsuji T; Hara H; Hara H; Nakamura M; Hirai H; Yamaguchi T
    Am Heart J; 2005 Oct; 150(4):681-8. PubMed ID: 16209964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of antibiotic therapy on outcomes of patients with coronary artery disease: a meta-analysis of randomized controlled trials.
    Andraws R; Berger JS; Brown DL
    JAMA; 2005 Jun; 293(21):2641-7. PubMed ID: 15928286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of Helicobacter pylori and Chlamydia pneumoniae DNA in human coronary arteries and evaluation of the results with serologic evidence of inflammation.
    Adiloglu AK; Ocal A; Can R; Duver H; Yavuz T; Aridogan BC
    Saudi Med J; 2005 Jul; 26(7):1068-74. PubMed ID: 16047055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Azithromycin effect on helicobacter pylori eradication: double blind randomized clinical trial.
    Rogha M; Pourmoghaddas Z; Rezaee M; Shirneshan K; Shahi Z
    Hepatogastroenterology; 2009; 56(91-92):722-4. PubMed ID: 19621690
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chlamydia pneumoniae and acute coronary syndrome.
    Wong BY; Gnarpe J
    N Engl J Med; 2005 Aug; 353(5):525-8; author reply 525-8. PubMed ID: 16079381
    [No Abstract]   [Full Text] [Related]  

  • 28. Role of omeprazole dosage and cytochrome P450 2C19 genotype in patients receiving omeprazole-amoxicillin dual therapy for Helicobacter pylori eradication.
    Yang JC; Wang HL; Chern HD; Shun CT; Lin BR; Lin CJ; Wang TH
    Pharmacotherapy; 2011 Mar; 31(3):227-38. PubMed ID: 21361732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of Levofloxacin, Clarithromycin and Esomeprazol as first line triple therapy for Helicobacter pylori eradication in Middle East. Prospective, randomized, blind, comparative, multicenter study.
    Assem M; El Azab G; Rasheed MA; Abdelfatah M; Shastery M
    Eur J Intern Med; 2010 Aug; 21(4):310-4. PubMed ID: 20603042
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Meta-analysis of randomized trials of antimicrobial drugs in the treatment of coronary heart disease].
    Skochko OV; Kaĭdashev IP
    Lik Sprava; 2012; (5):72-86. PubMed ID: 23534274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reverse sequential therapy achieves a similar eradication rate as standard sequential therapy for Helicobacter pylori eradication: a randomized controlled trial.
    Tsay FW; Wu DC; Kao SS; Tsai TJ; Lai KH; Cheng JS; Chan HH; Wang HM; Tsai WL; Tseng HH; Peng NJ; Hsu PI
    Helicobacter; 2015 Feb; 20(1):71-7. PubMed ID: 25495272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interrelationship of interleukin 6, C-reactive protein and Chlamydia pneumoniae IgG antibodies in patients with acute coronary syndromes.
    Burazor I; Vojdani A; Burazor M
    Vojnosanit Pregl; 2008 Jun; 65(6):425-33. PubMed ID: 18672698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibiotic treatment of atherosclerosis.
    Muhlestein JB
    Curr Opin Lipidol; 2003 Dec; 14(6):605-14. PubMed ID: 14624138
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antibodies against Chlamydophila in patients with acute myocardial infarction and coronary risk and their association with mortality].
    García-Elorriaga G; Sánchez-Barriga JJ; Ramos-Corrales MA; González-Bonilla C
    Salud Publica Mex; 2005; 47(3):227-33. PubMed ID: 16104465
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence and persistence of antibodies to herpes viruses, Chlamydia pneumoniae and Helicobacter pylori in Alaskan Eskimos: the GOCADAN Study.
    Zhu J; Davidson M; Leinonen M; Saikku P; Gaydos CA; Canos DA; Gutman KA; Howard BV; Epstein SE;
    Clin Microbiol Infect; 2006 Feb; 12(2):118-22. PubMed ID: 16441448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Malnutrition, infection and arteriovenous fistula failure: is there a link?
    Gagliardi GM; Rossi S; Condino F; Mancuso D; Greco F; Tenuta R; Savino O; Bonofiglio R; Domma F; Latorre G
    J Vasc Access; 2011; 12(1):57-62. PubMed ID: 21038306
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic role of Helicobacter pylori infection in acute coronary syndrome: a prospective cohort study.
    Eskandarian R; Ghorbani R; Shiyasi M; Momeni B; Hajifathalian K; Madani M
    Cardiovasc J Afr; 2012 Apr; 23(3):131-5. PubMed ID: 22555636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chlamydia pneumoniae and Helicobacter pylori infections and immunological profile of community-dwelling older adults.
    Noronha BP; Mambrini JVM; Torres KCL; Martins-Filho OA; Teixeira-Carvalho A; Lima-Costa MF; Peixoto SV
    Exp Gerontol; 2021 Dec; 156():111589. PubMed ID: 34637947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chlamydia pneumoniae and helicobacter pylori serology - importance in patients with coronary heart disease.
    Grdanoska T; Zafirovska P; Jaglikovski B; Pavlovska I; Zafirova B; Tosheska-Trajkovska K; Trajkovska-Dokic E; Petrovska M; Cekovska Z; Kondova-Topuzovska I; Georgievska-Ismail L; Panovski N
    Mater Sociomed; 2012; 24(3):151-6. PubMed ID: 23922522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Herpes Labialis, Chlamydophila pneumoniae, Helicobacter pylori, and Cytomegalovirus Infections and Risk of Dementia: The Framingham Heart Study.
    Zilli EM; O'Donnell A; Salinas J; Aparicio HJ; Gonzales MM; Jacob M; Beiser A; Seshadri S
    J Alzheimers Dis; 2021; 82(2):593-605. PubMed ID: 34057145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.